CD44 and melanoma: Reductive-responsive paclitaxel (PTX)-loaded HA-ss-TOS-PTX was efficiently taken up by CD44-induced endocytosis on CD44 overexpressing B16F10 melanoma cells, and exhibited enhanced cytotoxicity [94].